High blood pressure affects millions of adults around the world. In Peru, a massive look at nearly a quarter of a million people reveals where care often falls short. This analysis checked how well patients received treatment based on two major sets of expert rules from 2023 and 2025. The study looked at adults aged 18 and older across the country. It did not report specific numbers on who got better or who did not. It also did not list any side effects or safety issues because none were reported in the data. The main point is that the process of getting proper care, known as the care cascade, has holes. Many people with high blood pressure do not get the full attention these guidelines say they need. This gap means some patients might not get the help they deserve to keep their hearts healthy. The study used data from a repeated cross-sectional analysis, which looks at different groups of people over time. While the findings are important for understanding the current situation, the report does not say exactly how many people were affected in specific ways. The focus remains on the overall picture of care delivery in Peru.
Hypertension care cascade under dual guideline criteria was analyzed in 238,738 adults from PeruPeru adults with high blood pressure face gaps in standard care guidelines
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This repeated cross-sectional analysis evaluated the hypertension care cascade using dual guideline criteria from 2023 ESH and 2025 ACC/AHA. The study population consisted of 238,738 adults aged 18 years or older from Peru. The analysis was conducted in the Peru setting and did not report a specific comparator group. No primary outcomes, secondary outcomes, or follow-up duration were reported in the source document. Safety data including adverse events, serious adverse events, discontinuations, and tolerability were not reported. Funding sources and conflicts of interest were not reported. The authors did not provide specific practice relevance or certainty notes regarding the findings. Limitations of the study were not explicitly detailed in the provided information. Because the study is observational and lacks reported outcomes, causal interpretations cannot be made. Clinicians should interpret these data with caution given the missing outcome measures and lack of reported safety signals.